GSK Pharma Chief Exits After Losing CEO Spot

Jan. 19, 2017

GlaxoSmithKline's pharmaceuticals chief Abbas Hussain will be leaving the company after not being chosen to succeed outgoing Chief Executive Andrew Witty.

Hussain, who spent eight years at GSK, was one of a few top Glaxo execs beaten by former consumer healthcare boss Emma Walmsley for the CEO spot.

Hussain will be replaced by AstraZeneca executive Luke Miels -- Walmsley's first external appointment as CEO-designate.

Read the Marketwatch coverage